Friday, 25 April 2014

RG 7388 is a MDM2 inhibitor with superior potency and selectivity in phase 1 trials « New Drug Approvals

RG 7388 is a MDM2 inhibitor with superior potency and selectivity in phase 1 trials « New Drug Approvals:



'via Blog this'

1 comment: